A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to compare the relative bioavailability of Moexipril HCl 15mg tablets (by Paddock Laboratories, Inc.) with that of Univasc® 15mg tablets (by Schwarz Pharma) following a single oral dose (1 x 15mg tablet) in healthy, adult subjects under fasting conditions.

Key facts

Study ID

NCT00992862

Run by

Paddock Laboratories, Inc.

People needed

60

Last updated by the study team

2013-09-26

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Good health as determined by lack of clinically significant abnormalities in health assessment performed at screening

You may not qualify if…

• Positive test results for HIV or Hepatitis B or C
• History of allergy or sensitivity to Moexipril HCl or related drugs

Where it is running

• Novum Pharmaceutical Research Services — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.